Roundup Class Action Lawsuit Targets Lowe’s For Selling Dangerous Weedkiller To Consumers

A class action lawsuit has been filed against Loweโ€™s Home Centers, alleging that the store failed to warn consumers about known or potential Roundup health risks, including non-Hodgkins lymphoma and other side effects linked to the glyphosate-based weedkiller.

James Weeks filed the complaint (PDF) in the U.S. District Court for the Central District of California on August 6, naming Loweโ€™s Home Centers and up to 100 unnamed companies as defendants. The lawsuit seeks class action status to pursue damages for all purchasers of various Roundup products in California.

According to the Roundup class action, Loweโ€™s had a duty to inform consumers about the potential risks associated with the widely marketed weedkiller, but failed to do so at itโ€™s retail locations. The lawsuit indicates the company is provided a Safety Data Sheet (SDS) by the manufacturer, which indicates known risks. However, while the Safety Data Sheet warned that inhalation and skin contact are likely routes of exposure to the active ingredient, glyphosate, the label only warns of potential eye irritation.

Roundup-Cancer-Lawsuit-Lawyer
Roundup-Cancer-Lawsuit-Lawyer

In addition, the lawsuit notes there is no warning that glyphosate is probably a cancer-causing agent, a determination made by the World Health Organizationโ€™s International Agency for Research on Cancer (IARC) in 2015.

โ€œDespite its knowledge of the SDS, Defendant does not warn consumers they may be exposed to glyphosate through inhalation and skin contact,โ€ the lawsuit states. โ€œDefendant further omits proper use instructions, e.g. advising consumers to use a gas mask respirator when using Roundup. Reasonable consumers, like Plaintiff, who have purchased Roundup would not have done so had they known of its carcinogenic risks, or had Defendant provided a warning on how to minimize these risks.โ€

The lawsuit asks the Court to require Loweโ€™s to pay restitution to any California residents who purchased Roundup products at its stores.

The complaint was filed just one day before the U.S. Environmental Protection Agency (EPA) issued a guidance, indicating it will not approve products which carry a label warning required by the state of California to alert consumers that Roundup may cause cancer.

The EPA claims the label requirement, part of Californiaโ€™s Proposition 65 list of hazardous agents, is false and misleading since it does not agree with the IARCโ€™s findings.

Monsanto and Bayer face increasing pressure to settle Roundup lawsuits filed by more than 18,500 individuals nationwide diagnosed with non-Hodgkins lymphoma after exposure to glyphosate in the weedkiller, as well as class action claims like this one.

After failing to convince U.S. juries that the weedkiller is safe, the company has been engaging in court ordered mediation to resolve failure to warn lawsuits pending throughout the U.S. Court system and Bayerโ€™s stock price has dropped substantially in recent months, signaling the extent of liability investors expect the company may have to pay to resolve the litigation.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




1 Comments


Brian k
Cancer from working at Lowe’s..Leukemia, Lymphoma also

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.
A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโ€™s lymphoma.
Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.